Improvement of solubility of celecoxib by inclusion in MCM-41 mesoporous silica: drug loading and release

Date

2015-01-01

Author

Gunaydin, Sahika
Yılmaz, Ayşen

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

137
views

0
downloads

Celecoxib is a poorly water-soluble nonsteroidal anti-inflammatory drug. Here we report four ordered mesoporous silica MCM-41 supports with different particle size, pore volume, and surface properties to investigate their loading capacity with celecoxib and their release abilities. Spherical MCM-41 mesoporous supports less than 50 nm in diameter were prepared and to compare the effect of the template removal process on morphology of samples, acid extraction and calcination methods were used. Moreover, nearly 500 nm sized rod-shaped MCM-41 mesoporous silica was obtained by changing the template concentration in preparation. Boron doping was performed to determine the effect of a heteroatom on the surface of mesoporous silica and adsorbance of drug molecules and release. In order to investigate the effect of polarity of solvent during drug loading, two different solvents were used: ethanol as polar solvent and hexane as nonpolar solvent. All bare and drug-loaded samples' physicochemical characterizations were performed. The release experiments were conducted in phosphate buffer solution of pH 7.4 at 37 degrees C. Celecoxib solubility was highly improved compared to the pure drug. The morphology and surface property differences of MCM-41 and the solvent effect in adsorption of celecoxib have been discussed, including its delivery.

Subject Keywords

Celecoxib, Borosilicate, Drug delivery system, MCM-41, Poorly water-soluble drugs

URI

https://hdl.handle.net/11511/49287

Journal

TURKISH JOURNAL OF CHEMISTRY

DOI

https://doi.org/10.3906/kim-1409-56

Collections

Department of Chemistry, Article

Suggestions

OpenMETU
Core

Biodegradation of the fluorinated non-steroidal anti-inflammatory pharmaceutical Flurbiprofen by environmental bacterial isolates Murdoch, Robert Waller(2015-12-31) Flurbiprofen is a fluorinated non-steroidal anti-inflammatory pharmaceutical. While flurbiprofen is quite popular in Turkey, there is at the present time no information as to how environmental bacteria degrade this chemical. Organisms capable of using flurbiprofen as sole carbon and energy source will be enriched from Ankara municipal sewage treatment plant. Strains will be isolated and identified using molecular methods. The general features of degradation pathways employed by unique strains will be cha...
Improved solubility of celecoxib by inclusion in SBA-15 mesoporous silica: Drug loading in different solvents and release Eren, Zeynep Seda; Tuncer, Sinem; Gezer, Gamze; Yildirim, Leyla Tatar; Banerjee, Sreeparna; Yılmaz, Ayşen (2016-11-15) In this study, celecoxib (CLX), a highly hydrophobic nonsteroidal anti-inflammatory drug with relatively low bioavailability, was used as a model drug to determine loading in different solvents and release properties from silica particles. Hydrothermal synthesis method was used to synthesize SBA-15 particles, which were functionalized by post-synthesis grafting method with (3-Aminopropyl) triethoxysilane (APTES). Additionally, boron doped SBA-15 samples were prepared to generate borosilicate samples. After ...
Reversal of multidrug resistance in mcf-7 breast adenocarcinoma cell line by silencing interleukin 6 with RNA interference Çakmak, Neşe; Gündüz, Ufuk; Department of Biology (2013) Multidrug resistance (MDR) in cancer is characterized by development of resistance to several unrelated drugs upon long time administration of a certain type of chemotherapeutic agent. In doxorubicin resistant MCF-7 cell line, resistance is developed mainly by upregulation of MDR1 gene which encodes an ABC transporter protein known as P-glycoprotein. Interleukin 6 (IL-6) is a cytokine which acts as a growth factor for certain cell types including some cancer cells. IL-6 is found at high levels in cancer pat...
Inclusion of celecoxib in the MCM – 41 mesoporous silica: drug loading and release property Günaydin, Şahika; Yılmaz, Ayşen; Department of Chemistry (2014) Mesoporous silica particles have been used to enhance the biocompability of the drugs and provide control drug release. Celecoxib was chosen as a model drug which is poorly water soluble non-steroidal anti-inflammatory drug. In this study, in order to determine the morphology effect on the drug loading capacity of the silica particles and release properties of the drug, MCM-41 particles were synthesized with different particle size, pore volume and surface properties. MCM-41-1 and MCM-41-2 labeled particles...
Alteration of protein and gene expressions of Hexokinase II in PC3 cell lines by cisplatinmetformin combination treatment Durukan, Özlem; Akkulak, Merve; Evin, Emre; Arslan, Şevki; Adalı, Orhan (null; 2018-07-01) Metformin is an antidiabetic drug with anticancer properties. Cisplatin is known as one of the most potent chemotherapeutics for treatment of various types of cancer. In order to overcome cisplatin resistance and toxicity, the drug can be combined with other drugs that sensitize tumour cells to cisplatin. The ability of metformin to potentiate cisplatin-mediated killing of cancer cells in vitro, makes it a plausible candidate for combination with cisplatin- based therapy. The aim of this study is to examine...

Citation Formats

S. Gunaydin and A. Yılmaz, “Improvement of solubility of celecoxib by inclusion in MCM-41 mesoporous silica: drug loading and release,” TURKISH JOURNAL OF CHEMISTRY, pp. 317–333, 2015, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/49287.